The importance of surgical therapy with expansion of TAVR to low-risk patients.
J Card Surg
; 34(12): 1432-1433, 2019 Dec.
Article
em En
| MEDLINE
| ID: mdl-31693240
ABSTRACT
Despite the landmark release of recent transcatheter aortic valve replacement data, the gold standard of surgical therapy is here to stay. Surgery remains vital in patient populations with low coronary height raising risk of coronary occlusion, aneurysmal ascending aorta, isolated aortic regurgitation, noncalcific disease, bicuspid valves, and multivessel coronary disease, or other structural abnormality requiring cardiac surgery. Consideration of these issues highlights the ongoing importance of multidisciplinary consideration of individual patient cases, careful review of imaging, and preservation of a robust surgical program to complement transcatheter development. As the landscape of valvular heart disease management continues to evolve, the surgeon's role is changing, but by no means diminished and their engagement in heart team decision making remains paramount.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Implante de Prótese de Valva Cardíaca
/
Substituição da Valva Aórtica Transcateter
/
Doenças das Valvas Cardíacas
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article